Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Shareholders Have the Information They Need to Make an Informed VotePreliminary Net Sales Results for Third Quarter Underscore ...
Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood's Concerns ...
STAAR Surgical Company (NASDAQ:STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Col...
Raises Concerns About Whether the Board Fulfilled Its Fiduciary Duty of Care in Doubling Down on Its Commitment to Proposed Tra...
Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or th...
STAAR Continues to Significantly Underestimate the Strength of the Business and Future Prospects and Misrepresent Its Performan...
Contends There Is No Business Justification for the Board's Decision to Sell the Company for $28 Per Share Now After Reject...
Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...
Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...
